Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension.
Asmar
Roland
R
Institut de Recherche et de Formation CardioVasculaire, Paris, France.
Sayegh
Fady
F
Tracz
Wiesława
W
Hlawaty
Marta
M
Olszowska
Maria
M
Jourde
Michel
M
Vincent
Marc
M
Goujoun
Bernard
B
Maldonado
Joao
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D007546:Isoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D044005:Tetrahydroisoquinolines; D014463:Ultrasonography
D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; C058302:moexipril